Patents
Patents for C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
03/2010
03/10/2010EP1423376B1 Bicyclic compound, production and use thereof
03/10/2010EP1023315B1 Methods and compositions for destruction of selected proteins
03/02/2010US7671190 Transformed host cells that make the anticancer polyketides herbimycin and geldanamycin; biosynthesis
02/2010
02/24/2010CN100591673C Herbimycin derivant, preparation method and antineoplastic application thereof
02/18/2010US20100041640 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
02/17/2010CN101652348A C21-de0xy ansamycin derivatives as antitumor agents
02/16/2010US7663301 for use as robust red organic phosphors
02/16/2010US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
02/16/2010CA2287387C Methods and compositions for destruction of selected proteins
02/04/2010WO2010012812A1 Benzazepines and benzazocines as sigma-receptor ligandes
02/04/2010US20100029932 Process for production of amide or lactam
02/04/2010DE102008035596A1 Derivate benzoannelierter Stickstoff-Heterocyclen Derivatives benzoannelierter nitrogen heterocycles
01/2010
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
01/19/2010US7648976 Potential as an anticancer agent; an inhibitor of heat shock protein-90; superior for the preparation of dispersion-based pharmaceutical formulations
01/14/2010US20100009959 Pentacyclic Indole Derivatives as Antiviral Agents
01/13/2010EP2142595A1 Oxime free anti-skinning combination
01/12/2010US7645872 Compounds and methods for labeling oligonucleotides
12/2009
12/24/2009US20090318416 Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/16/2009EP1904057B1 Hydroquinone ansamycins in the treatment of gastrointestinal stromal tumors
12/15/2009CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/10/2009US20090306368 Polynuclear complex
12/10/2009US20090306367 Process for preparing amides from ketoximes
12/09/2009EP2129662A2 C21-deoxy ansamycin derivatives as antitumor agents
12/03/2009US20090298804 Novel Compounds and Methods for Their Production
12/03/2009US20090297454 Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use
12/02/2009CN101595095A 18, 21-didesoxymacbecin derivatives for the treatment of cancer
11/2009
11/26/2009WO2009142206A1 Process for producing laurolactam
11/25/2009EP2123635A1 Method for production of laurolactam
11/25/2009EP2121957A1 Macrolactams by engineered biosynthesis
11/25/2009CN101585809A Novel compound with antibacterial and antitumor activities
11/19/2009WO2009138542A1 Use of hsp90 protein inhibiting compounds and pharmaceutical composition intended for anti-tumour therapy
11/18/2009CN101580815A Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof
11/11/2009EP2116529A1 Process for production of amide or lactam
11/11/2009CN101578268A Novel compounds and methods for their production
11/11/2009CN101578267A 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
11/05/2009WO2009134987A1 Difluoromethyl-containing macrocyclic compounds as hepatitis c virus inhibitors
11/05/2009WO2009133801A1 Process for production of amide or lactam
11/04/2009CN101573333A Inhibitors of histone deacetylase
10/2009
10/29/2009WO2009130706A1 A process for isolation and purification of geldanamycin
10/27/2009US7608613 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/27/2009US7608611 18,21-didehydro-18,21-dideoxo-18,21-dihydroxy-geldanamycin derivatives as anticarcinogenic agent; with a metal chelating agent
10/22/2009US20090264397 Highly fluorinated oils and surfactants and methods of making and using same
10/21/2009CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof
10/15/2009WO2009125720A1 Laurolactam production method
10/13/2009US7601695 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal
10/08/2009US20090253667 18 ,21-Didesoxymacbecin Derivatives for the Treatment of Cancer
10/08/2009US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/07/2009CN101550046A A method for synthesis of medium-ring compounds of 9 to 12 rings
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
09/2009
09/30/2009CN101547908A Heterocyclic derived metalloprotease inhibitors
09/24/2009WO2009117594A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors
09/24/2009WO2009116537A1 Manufacturing method for laurolactam
09/24/2009US20090240050 reacting macrocyclic metal-free cyanine compound dissolved in solvent and vanadium acetylacetonate; low cost
09/11/2009WO2009110938A2 Novel macrocyclic polyene lactams
09/09/2009EP2098512A1 Compounds and methods for treating dyslipidemia
09/09/2009EP1670768B1 Compounds and methods for treating dyslipidemia
09/09/2009CN101528705A Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor
09/02/2009EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation
09/01/2009US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
08/2009
08/26/2009EP2091919A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer
08/25/2009US7579463 Crown ether derivatives
08/25/2009US7579462 Reacting allyl amine and geldanamycin in volatile aprotic solvent (tetrahydrofuran), concentrating by evaporation, adding volatile protic solvent (iisopropanol), removing protic solvent to purify, then filtering; making 17-allylamino-geldanamycin (Tanespimycin)
08/25/2009US7579337 Analogs of benzoquinone-containing ansamycins and methods of use thereof
08/20/2009WO2009004146A3 Novel herbimycin a analogue derivatives, compositions containing same and use thereof
08/20/2009US20090209593 Novel antibacterial agents
08/20/2009US20090209549 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
08/20/2009US20090209507 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies
08/20/2009US20090209494 21-deoxymacbecin analogues useful as antitumor agents
08/20/2009US20090208590 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
08/19/2009EP2089365A1 Heterocyclic derived metalloprotease inhibitors
08/13/2009WO2009099134A1 Production method and beckmann rearrangement catalyst for producing a cyclic lactam compound
08/13/2009WO2008145525A3 Process for the preparation of dibenzo [b,d]azepin-6-one derivative
08/13/2009US20090203739 Anti-Inflammatory Agents
08/13/2009US20090202521 Bifunctional Polyazamacrocyclic Chelating Agents
08/06/2009US20090198050 Macrocyclic Modulators of the Ghrelin Receptor
08/05/2009CN101500997A PARP inhibitors
07/2009
07/30/2009WO2009094443A1 Difluorinated tripeptides as hcv serine protease inhibitors
07/30/2009WO2009092295A1 A set of geldanamycin derivatives and their preparation methods
07/30/2009CA2713005A1 Difluorinated tripeptides as hcv serine protease inhibitors
07/29/2009CN100519536C Group of geldanamycin derivative with nucleoside base
07/28/2009US7566706 Drug delivery methods of 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
07/23/2009US20090186905 Anaplastic lymphoma kinase modulators and methods of use
07/23/2009CA2755876A1 Synthesis of resorcylic acid lactones useful as therapeutic agents
07/22/2009EP2079700A1 18, 21-didesoxymacbecin derivatives for the treatment of cancer
07/16/2009US20090180984 Macrocyclic oximyl hepatitis c serine protease inhibitors
07/16/2009US20090180983 Bicyclic, c5-substituted proline derivatives as inhibitors of the hepatitis c virus ns3 protease
07/15/2009EP1765073A4 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
07/08/2009EP1278726B1 Method for producing cyclic lactams
07/02/2009US20090170878 Macrocyclic compounds useful as bace inhibitors
06/2009
06/18/2009US20090155829 Heme choline esters and uses thereof
06/17/2009EP1472230B1 Ansamycins having improved pharmacological and biological properties
06/17/2009CN101460465A 18,21-didesoxymacbecin derivatives for the treatment of cancer
06/16/2009US7547705 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes
06/11/2009US20090149395 Novel macrocyclic polyene lactams
06/04/2009WO2009069522A1 Method for production of laurolactam
06/04/2009WO2007061878A3 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
05/2009
05/20/2009CN101437802A 17-oxymacbecin derivatives and their use in the treatment of cancer and/or B-cell malignancies
05/12/2009US7531543 Phenylpiperazine cycloalkanol derivatives and methods of their use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 17